TaiGen Biopharmaceuticals Holdings Competitors and Similar CompaniesClear all
TaiGen Biopharmaceuticals Holdings's competitors and similar companies include Cipla.
 TaiGen Biopharmaceuticals Holdings TaiGen Biopharmaceuticals Holdings (太景醫藥研發控股股份有限公司) is a company that focuses on the development of therapeutics for diseases such as cancer, infections, and diabetic complications. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | |
Founding Date | Founding Date 2005 | Founding Date 1935 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Taipei, TW HQ | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more |
Employees | Employees 498% decrease | Employees 27,764 |
Financial | ||
Revenue (est.) | Revenue (est.) NT$259.5m (FY, 2025) | Revenue (est.) ₹277.1b (FY, 2026) |
Cost of goods | Cost of goods NT$18.2m (FY, 2025) | Cost of goods ₹95.5b (FY, 2026) |
Gross profit | Gross profit NT$242.8m (FY, 2025) | Gross profit ₹195b (FY, 2026) |
Net income | Net income NT$45.2m (FY, 2025) | Net income ₹38.7b (FY, 2026) |
For sources of this data, please see the company profile
View Company Profiles
Cipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View company